6 completed. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 2 |
Follow VX-150: new trials by email Literature Review of VX-150 trials Research Report on VX-150
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Microneurography Study of NaV1.8 Inhibition in Healthy Adults VX-150, VX-548, VX-993 - Pain | Phase 1 | Completed | Vertex Pharmaceuticals Incorporated | 92 | 2024-05-21 | 2025-04-20 |
| A Microneurography (MNG) Study of VX-150 in Healthy Participants Placebo, VX-150 - Pain | Phase 1 | Completed | Vertex Pharmaceuticals Incorporated | 45 | 2022-06-16 | 2022-10-14 |
| A Dose-ranging Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy VX-150, Placebo - Acute Pain | Phase 2 | Completed | Vertex Pharmaceuticals Incorporated | 250 | 2018-12-12 | 2022-02-09 |
| A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy VX-150, Placebo - Small Fiber Neuropathy | Phase 2 | Completed | Vertex Pharmaceuticals Incorporated | 89 | 2017-09-20 | 2021-11-15 |
| A Study to Evaluate Efficacy and Safety of VX-150 in Subjects With Acute Pain Following Bunionectomy VX-150, HB/APAP, Placebo - Acute Pain | Phase 2 | Completed | Vertex Pharmaceuticals Incorporated | 243 | 2017-06-29 | 2021-02-03 |
| A Study of the Efficacy and Safety of VX-150 in Subjects With Osteoarthritis of the Knee VX-150, Placebo - Osteoarthritis | Phase 2 | Completed | Vertex Pharmaceuticals Incorporated | 124 | 2015-12-01 | 2020-09-30 |
Acute Pain (2) · Pain (2) · Osteoarthritis (1) · Small Fiber Neuropathy (1)
Vertex Pharmaceuticals Incorporated (6)
United States (4) · United Kingdom (2) · Germany (1) · Italy (1) · Netherlands (1)
2017 (1)